Alkermes’ Corporate Presentation to be Webcast at Two Upcoming Conferences

Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Jefferies 2012 Global Healthcare Conference on Wednesday, November 14, 2012, at 9:20 a.m. GMT (4:20 a.m. EST) in London. In addition, Alkermes’ corporate presentation will be webcast live at the Credit Suisse 2012 Healthcare Conference on Wednesday, November 14, 2012, at 3:00 p.m. MST (5:00 p.m. EST/10:00 p.m. GMT) from Phoenix, Arizona. These presentations may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

Alkermes plc is a fully integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to develop innovative medicines that improve patient outcomes. The company has a diversified portfolio of more than 20 commercial drug products and a substantial clinical pipeline of product candidates that address central nervous system (CNS) disorders such as addiction, schizophrenia and depression. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and manufacturing facilities in Gainesville, Georgia and Wilmington, Ohio. For more information, please visit Alkermes’ website at www.alkermes.com.

Contacts:

Alkermes plc
Eva Stroynowski, +1 781-609-6823
Corporate Communications
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here
//-->